aluates Reports

$ 0.0

Automative

Global Biosimilars of Factor X agonists Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-37O18811

BUY CHAPTERS

Global Biosimilars of Factor X agonists Market Research Report 2024

Code: QYRE-Auto-37O18811

Report

December 2024

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Generium

AryoGen Pharmed

Amega Biotech

Biosimilars of Factor X agonists Market Size

The global market for Biosimilars of Factor X agonists was valued at US$ 227 million in the year 2023 and is projected to reach a revised size of US$ 310 million by 2030, growing at a CAGR of 4.6% during the forecast period.

Biosimilars of Factor X agonists Market

Biosimilars of Factor X agonists are a class of subsequent biological products that are comparable to approved F10 stimulants (i.e., clotting factor X activators). They effectively control and prevent bleeding events in patients with hemophilia A and B by activating the clotting cascade. These biosimilars are comparable to the original drugs in quality, safety and efficacy, while at a lower cost, providing patients with a more economical treatment option.

North American market for Biosimilars of Factor X agonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Biosimilars of Factor X agonists is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Biosimilars of Factor X agonists include Generium, AryoGen Pharmed, AMEGA Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biosimilars of Factor X agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars of Factor X agonists.

The Biosimilars of Factor X agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimilars of Factor X agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosimilars of Factor X agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosimilars of Factor X agonists Market Report

Report Metric	Details
Report Name	Biosimilars of Factor X agonists Market
Accounted market size in year	US$ 227 million
Forecasted market size in 2030	US$ 310 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2030
by Type	1.2mg 2.4mg
by Application	Hospital Clinic Others
Production by Region	North America Europe
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Generium, AryoGen Pharmed, AMEGA Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biosimilars of Factor X agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biosimilars of Factor X agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Biosimilars of Factor X agonists Market growing?

Ans: The Biosimilars of Factor X agonists Market witnessing a CAGR of 4.6% during the forecast period 2025-2030.

What is the Biosimilars of Factor X agonists Market size in 2030?

Ans: The Biosimilars of Factor X agonists Market size in 2030 will be US$ 310 million.

Who are the main players in the Biosimilars of Factor X agonists Market report?

Ans: The main players in the Biosimilars of Factor X agonists Market are Generium, AryoGen Pharmed, AMEGA Biotech

What are the Application segmentation covered in the Biosimilars of Factor X agonists Market report?

Ans: The Applications covered in the Biosimilars of Factor X agonists Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Biosimilars of Factor X agonists Market report?

Ans: The Types covered in the Biosimilars of Factor X agonists Market report are 1.2mg, 2.4mg

Recommended Reports

Hemophilia & Blood Disorders

Biosimilars & Biologics

Coagulation & Thrombosis

1 Biosimilars of Factor X agonists Market Overview

1.1 Product Definition

1.2 Biosimilars of Factor X agonists by Type

1.2.1 Global Biosimilars of Factor X agonists Market Value Comparison by Type (2024-2030)

1.2.2 1.2mg

1.2.3 2.4mg

1.3 Biosimilars of Factor X agonists by Application

1.3.1 Global Biosimilars of Factor X agonists Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Biosimilars of Factor X agonists Market Size Estimates and Forecasts

1.4.1 Global Biosimilars of Factor X agonists Revenue 2019-2030

1.4.2 Global Biosimilars of Factor X agonists Sales 2019-2030

1.4.3 Global Biosimilars of Factor X agonists Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Biosimilars of Factor X agonists Market Competition by Manufacturers

2.1 Global Biosimilars of Factor X agonists Sales Market Share by Manufacturers (2019-2024)

2.2 Global Biosimilars of Factor X agonists Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Biosimilars of Factor X agonists Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Biosimilars of Factor X agonists, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Biosimilars of Factor X agonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Biosimilars of Factor X agonists, Product Type & Application

2.7 Global Key Manufacturers of Biosimilars of Factor X agonists, Date of Enter into This Industry

2.8 Global Biosimilars of Factor X agonists Market Competitive Situation and Trends

2.8.1 Global Biosimilars of Factor X agonists Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Biosimilars of Factor X agonists Players Market Share by Revenue

2.8.3 Global Biosimilars of Factor X agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Biosimilars of Factor X agonists Market Scenario by Region

3.1 Global Biosimilars of Factor X agonists Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Biosimilars of Factor X agonists Sales by Region: 2019-2030

3.2.1 Global Biosimilars of Factor X agonists Sales by Region: 2019-2024

3.2.2 Global Biosimilars of Factor X agonists Sales by Region: 2025-2030

3.3 Global Biosimilars of Factor X agonists Revenue by Region: 2019-2030

3.3.1 Global Biosimilars of Factor X agonists Revenue by Region: 2019-2024

3.3.2 Global Biosimilars of Factor X agonists Revenue by Region: 2025-2030

3.4 North America Biosimilars of Factor X agonists Market Facts & Figures by Country

3.4.1 North America Biosimilars of Factor X agonists Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Biosimilars of Factor X agonists Sales by Country (2019-2030)

3.4.3 North America Biosimilars of Factor X agonists Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Biosimilars of Factor X agonists Market Facts & Figures by Country

3.5.1 Europe Biosimilars of Factor X agonists Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Biosimilars of Factor X agonists Sales by Country (2019-2030)

3.5.3 Europe Biosimilars of Factor X agonists Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Biosimilars of Factor X agonists Market Facts & Figures by Region

3.6.1 Asia Pacific Biosimilars of Factor X agonists Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Biosimilars of Factor X agonists Sales by Region (2019-2030)

3.6.3 Asia Pacific Biosimilars of Factor X agonists Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Biosimilars of Factor X agonists Market Facts & Figures by Country

3.7.1 Latin America Biosimilars of Factor X agonists Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Biosimilars of Factor X agonists Sales by Country (2019-2030)

3.7.3 Latin America Biosimilars of Factor X agonists Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Biosimilars of Factor X agonists Market Facts & Figures by Country

3.8.1 Middle East and Africa Biosimilars of Factor X agonists Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Biosimilars of Factor X agonists Sales by Country (2019-2030)

3.8.3 Middle East and Africa Biosimilars of Factor X agonists Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Biosimilars of Factor X agonists Sales by Type (2019-2030)

4.1.1 Global Biosimilars of Factor X agonists Sales by Type (2019-2024)

4.1.2 Global Biosimilars of Factor X agonists Sales by Type (2025-2030)

4.1.3 Global Biosimilars of Factor X agonists Sales Market Share by Type (2019-2030)

4.2 Global Biosimilars of Factor X agonists Revenue by Type (2019-2030)

4.2.1 Global Biosimilars of Factor X agonists Revenue by Type (2019-2024)

4.2.2 Global Biosimilars of Factor X agonists Revenue by Type (2025-2030)

4.2.3 Global Biosimilars of Factor X agonists Revenue Market Share by Type (2019-2030)

4.3 Global Biosimilars of Factor X agonists Price by Type (2019-2030)

5 Segment by Application

5.1 Global Biosimilars of Factor X agonists Sales by Application (2019-2030)

5.1.1 Global Biosimilars of Factor X agonists Sales by Application (2019-2024)

5.1.2 Global Biosimilars of Factor X agonists Sales by Application (2025-2030)

5.1.3 Global Biosimilars of Factor X agonists Sales Market Share by Application (2019-2030)

5.2 Global Biosimilars of Factor X agonists Revenue by Application (2019-2030)

5.2.1 Global Biosimilars of Factor X agonists Revenue by Application (2019-2024)

5.2.2 Global Biosimilars of Factor X agonists Revenue by Application (2025-2030)

5.2.3 Global Biosimilars of Factor X agonists Revenue Market Share by Application (2019-2030)

5.3 Global Biosimilars of Factor X agonists Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Generium

6.1.1 Generium Company Information

6.1.2 Generium Description and Business Overview

6.1.3 Generium Biosimilars of Factor X agonists Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Generium Biosimilars of Factor X agonists Product Portfolio

6.1.5 Generium Recent Developments/Updates

6.2 AryoGen Pharmed

6.2.1 AryoGen Pharmed Company Information

6.2.2 AryoGen Pharmed Description and Business Overview

6.2.3 AryoGen Pharmed Biosimilars of Factor X agonists Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AryoGen Pharmed Biosimilars of Factor X agonists Product Portfolio

6.2.5 AryoGen Pharmed Recent Developments/Updates

6.3 AMEGA Biotech

6.3.1 AMEGA Biotech Company Information

6.3.2 AMEGA Biotech Description and Business Overview

6.3.3 AMEGA Biotech Biosimilars of Factor X agonists Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AMEGA Biotech Biosimilars of Factor X agonists Product Portfolio

6.3.5 AMEGA Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Biosimilars of Factor X agonists Industry Chain Analysis

7.2 Biosimilars of Factor X agonists Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Biosimilars of Factor X agonists Production Mode & Process

7.4 Biosimilars of Factor X agonists Sales and Marketing

7.4.1 Biosimilars of Factor X agonists Sales Channels

7.4.2 Biosimilars of Factor X agonists Distributors

7.5 Biosimilars of Factor X agonists Customers

8 Biosimilars of Factor X agonists Market Dynamics

8.1 Biosimilars of Factor X agonists Industry Trends

8.2 Biosimilars of Factor X agonists Market Drivers

8.3 Biosimilars of Factor X agonists Market Challenges

8.4 Biosimilars of Factor X agonists Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Generium

AryoGen Pharmed

Amega Biotech

List of Tables

Table 1. Global Biosimilars of Factor X agonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Biosimilars of Factor X agonists Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Biosimilars of Factor X agonists Market Competitive Situation by Manufacturers in 2023

Table 4. Global Biosimilars of Factor X agonists Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Biosimilars of Factor X agonists Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Biosimilars of Factor X agonists Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Biosimilars of Factor X agonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Biosimilars of Factor X agonists, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Biosimilars of Factor X agonists, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Biosimilars of Factor X agonists, Product Type & Application

Table 12. Global Key Manufacturers of Biosimilars of Factor X agonists, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Biosimilars of Factor X agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars of Factor X agonists as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Biosimilars of Factor X agonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Biosimilars of Factor X agonists Sales by Region (2019-2024) & (K Units)

Table 18. Global Biosimilars of Factor X agonists Sales Market Share by Region (2019-2024)

Table 19. Global Biosimilars of Factor X agonists Sales by Region (2025-2030) & (K Units)

Table 20. Global Biosimilars of Factor X agonists Sales Market Share by Region (2025-2030)

Table 21. Global Biosimilars of Factor X agonists Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Biosimilars of Factor X agonists Revenue Market Share by Region (2019-2024)

Table 23. Global Biosimilars of Factor X agonists Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Biosimilars of Factor X agonists Revenue Market Share by Region (2025-2030)

Table 25. North America Biosimilars of Factor X agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Biosimilars of Factor X agonists Sales by Country (2019-2024) & (K Units)

Table 27. North America Biosimilars of Factor X agonists Sales by Country (2025-2030) & (K Units)

Table 28. North America Biosimilars of Factor X agonists Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Biosimilars of Factor X agonists Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Biosimilars of Factor X agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Biosimilars of Factor X agonists Sales by Country (2019-2024) & (K Units)

Table 32. Europe Biosimilars of Factor X agonists Sales by Country (2025-2030) & (K Units)

Table 33. Europe Biosimilars of Factor X agonists Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Biosimilars of Factor X agonists Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Biosimilars of Factor X agonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Biosimilars of Factor X agonists Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Biosimilars of Factor X agonists Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Biosimilars of Factor X agonists Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Biosimilars of Factor X agonists Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Biosimilars of Factor X agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Biosimilars of Factor X agonists Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Biosimilars of Factor X agonists Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Biosimilars of Factor X agonists Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Biosimilars of Factor X agonists Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Biosimilars of Factor X agonists Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Biosimilars of Factor X agonists Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Biosimilars of Factor X agonists Sales (K Units) by Type (2019-2024)

Table 51. Global Biosimilars of Factor X agonists Sales (K Units) by Type (2025-2030)

Table 52. Global Biosimilars of Factor X agonists Sales Market Share by Type (2019-2024)

Table 53. Global Biosimilars of Factor X agonists Sales Market Share by Type (2025-2030)

Table 54. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Biosimilars of Factor X agonists Revenue Market Share by Type (2019-2024)

Table 57. Global Biosimilars of Factor X agonists Revenue Market Share by Type (2025-2030)

Table 58. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2019-2024)

Table 59. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2025-2030)

Table 60. Global Biosimilars of Factor X agonists Sales (K Units) by Application (2019-2024)

Table 61. Global Biosimilars of Factor X agonists Sales (K Units) by Application (2025-2030)

Table 62. Global Biosimilars of Factor X agonists Sales Market Share by Application (2019-2024)

Table 63. Global Biosimilars of Factor X agonists Sales Market Share by Application (2025-2030)

Table 64. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Biosimilars of Factor X agonists Revenue Market Share by Application (2019-2024)

Table 67. Global Biosimilars of Factor X agonists Revenue Market Share by Application (2025-2030)

Table 68. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2019-2024)

Table 69. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2025-2030)

Table 70. Generium Company Information

Table 71. Generium Description and Business Overview

Table 72. Generium Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Generium Biosimilars of Factor X agonists Product

Table 74. Generium Recent Developments/Updates

Table 75. AryoGen Pharmed Company Information

Table 76. AryoGen Pharmed Description and Business Overview

Table 77. AryoGen Pharmed Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AryoGen Pharmed Biosimilars of Factor X agonists Product

Table 79. AryoGen Pharmed Recent Developments/Updates

Table 80. AMEGA Biotech Company Information

Table 81. AMEGA Biotech Description and Business Overview

Table 82. AMEGA Biotech Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AMEGA Biotech Biosimilars of Factor X agonists Product

Table 84. AMEGA Biotech Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Biosimilars of Factor X agonists Distributors List

Table 88. Biosimilars of Factor X agonists Customers List

Table 89. Biosimilars of Factor X agonists Market Trends

Table 90. Biosimilars of Factor X agonists Market Drivers

Table 91. Biosimilars of Factor X agonists Market Challenges

Table 92. Biosimilars of Factor X agonists Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Biosimilars of Factor X agonists

Figure 2. Global Biosimilars of Factor X agonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Biosimilars of Factor X agonists Market Share by Type: 2023 & 2030

Figure 4. 1.2mg Product Picture

Figure 5. 2.4mg Product Picture

Figure 6. Global Biosimilars of Factor X agonists Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Biosimilars of Factor X agonists Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Biosimilars of Factor X agonists Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Biosimilars of Factor X agonists Market Size (2019-2030) & (US$ Million)

Figure 13. Global Biosimilars of Factor X agonists Sales (2019-2030) & (K Units)

Figure 14. Global Biosimilars of Factor X agonists Average Price (US$/Unit) & (2019-2030)

Figure 15. Biosimilars of Factor X agonists Report Years Considered

Figure 16. Biosimilars of Factor X agonists Sales Share by Manufacturers in 2023

Figure 17. Global Biosimilars of Factor X agonists Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Biosimilars of Factor X agonists Players: Market Share by Revenue in Biosimilars of Factor X agonists in 2023

Figure 19. Biosimilars of Factor X agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Biosimilars of Factor X agonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Biosimilars of Factor X agonists Sales Market Share by Country (2019-2030)

Figure 22. North America Biosimilars of Factor X agonists Revenue Market Share by Country (2019-2030)

Figure 23. United States Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Biosimilars of Factor X agonists Sales Market Share by Country (2019-2030)

Figure 26. Europe Biosimilars of Factor X agonists Revenue Market Share by Country (2019-2030)

Figure 27. Germany Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Biosimilars of Factor X agonists Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Biosimilars of Factor X agonists Revenue Market Share by Region (2019-2030)

Figure 34. China Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Biosimilars of Factor X agonists Sales Market Share by Country (2019-2030)

Figure 42. Mexico Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Biosimilars of Factor X agonists Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Biosimilars of Factor X agonists Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Biosimilars of Factor X agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Biosimilars of Factor X agonists by Type (2019-2030)

Figure 52. Global Revenue Market Share of Biosimilars of Factor X agonists by Type (2019-2030)

Figure 53. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Biosimilars of Factor X agonists by Application (2019-2030)

Figure 55. Global Revenue Market Share of Biosimilars of Factor X agonists by Application (2019-2030)

Figure 56. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2019-2030)

Figure 57. Biosimilars of Factor X agonists Value Chain

Figure 58. Biosimilars of Factor X agonists Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Antihemophilic Factor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Haemophilia Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia A Drug Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia Medication Market Research Report 2024

Global Interchangeable Biosimilars Market Research Report 2024

Global Recombinant Activated Coagulation Factor VII Market Research Report 2025

Alprolix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Emicizumab Injection Market Research Report 2024

Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriasis Biosimilar Market Research Report 2024

Global FXa Inhibitor Market Research Report 2025

Global Blood Clot Activator BCA Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions